Balanced news tone
News Sentiment
NEOG sentiment intelligence
Neogen Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
42 relevant articles
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
+3.0% over one week, +5.7% over four weeks, trend inactive, and below fair value.
Neogen (NASDAQ:NEOG) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
77/100 classification
One-week reaction
3.0%
Price confirming higher
Trend fit
Trend inactive
5.7% over four weeks
Fair value
-20.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
5
Neutral
31
Negative
6
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Industry context
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
MarketBeat
Direct company coverage
Neogen (NASDAQ:NEOG) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jul 2026 07:20
- Source
- MarketBeat
Stock Titan
Direct company coverage
Neuberger Berman discloses 7.6% stake in Neogen (NEOG) via fiduciary accounts
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 20:48
- Source
- Stock Titan
simplywall.st
Direct company coverage
How Analyst Concerns Over Capital Efficiency And Equity Needs Could Impact Neogen (NEOG) Investors
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 04 Jul 2026 17:34
- Source
- simplywall.st
Zacks
Direct company coverage
Neogen Gains 101.1% in a Year: What's Driving the Rally?
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 26 Jun 2026 14:03
- Source
- Zacks
simplywall.st
Direct company coverage
Neogen (NEOG) Stock Could Be 26.4% Undervalued After Texas And Florida Product Expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- simplywall.st
Business Wire
Direct company coverage
Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 12:45
- Source
- Business Wire
Stock Titan
Direct company coverage
Neogen adds Texas, Florida fly-control tools for New World screwworm
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Stock Titan
Market source
Industry context
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
NEOGEN (NEOG) CAO has shares withheld to cover RSU tax obligations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Stock Titan
Simply Wall St.
Direct company coverage
How Investors Are Reacting To Neogen (NEOG) Petrifilm Shift and Operational Efficiency Push
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 06:11
- Source
- Simply Wall St.
Motley Fool
Direct company coverage
Neogen (NEOG) Q3 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2026 15:48
- Source
- Motley Fool
Stock Titan
Direct company coverage
[144] NEOGEN CORP SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Stock Titan
Market source
Industry context
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is Weaker Sales And Returns Reshaping The Investment Case For Neogen’s (NEOG) Valuation Assumptions?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Market source
StockStory
Industry context
Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- StockStory
StockStory
Direct company coverage
Neogen and Baxter Shares Are Falling, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- StockStory
Market source
Industry context
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
5 Must-Read Analyst Questions From Neogen’s Q1 Earnings Call
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Assessing Neogen (NEOG) Valuation After Earnings Beat And Higher Full Year Guidance
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 12 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
The Bull Case For Neogen (NEOG) Could Change Following Q3 Loss, Guidance Hike, Genomics Sale News
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 12 Apr 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Neogen Reshapes Portfolio Around Food Safety With Divestitures And Job Cuts
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 12 Apr 2026 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Neogen (NEOG) Q3 Losses Keep Margin Concerns Central To Bullish Discount Narrative
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Apr 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Is Neogen (NEOG) Now Offering Value After Its Strong Year To Date Share Price Gain
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 08 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Neogen (NEOG) Q1 Earnings Report Preview: What To Look For
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Evrim Ağacı
Direct company coverage
Neogen Labor Rally Sparks Investor Uncertainty In Michigan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Mar 2026 07:00
- Source
- Evrim Ağacı
Market source
Industry context
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source